open access
Clinical applications of 18F fluoro-2-deoxy-D-glucose (FDG) positron emission tomography- computed tomography (PET/CT)
open access
Abstract
diagnostic imaging modality. Coupled with computed tomography
(CT), it has a high accuracy, adding morphological informations.
F-18 fluoro-2-deoxy-D-glucose (FDG), an analogue
of glucose, is the most commonly used radiotracer. Its uptake
reflects glucose metabolism in the cells which is increased
several times in malignant tumors. However FDG is not a cancer
specific agent and its uptake has been described in a number
of non-neoplastic inflammatory lesions. The aim of our paper
is to summarize its major indications in the clinical practice.
Abstract
diagnostic imaging modality. Coupled with computed tomography
(CT), it has a high accuracy, adding morphological informations.
F-18 fluoro-2-deoxy-D-glucose (FDG), an analogue
of glucose, is the most commonly used radiotracer. Its uptake
reflects glucose metabolism in the cells which is increased
several times in malignant tumors. However FDG is not a cancer
specific agent and its uptake has been described in a number
of non-neoplastic inflammatory lesions. The aim of our paper
is to summarize its major indications in the clinical practice.
Keywords
fluorodeoxyglucose, positron emission tomography, computed tomography
About this articleTitle
Clinical applications of 18F fluoro-2-deoxy-D-glucose (FDG) positron emission tomography- computed tomography (PET/CT)
Journal
Issue
Pages
48-51
Published online
2013-02-19
Page views
516
Article views/downloads
1948
Keywords
fluorodeoxyglucose
positron emission tomography
computed tomography
Authors
Lucia Zanoni
Abdulaziz Saleh Al-Sugair
Stefano Fanti
